Nobody knows for sure what happened to TonyCorvette, but

New Post Public Reply Private Reply Replies (2) Message Board
Respert24 Goosebumbs22 #151449
679
Nobody knows for sure what happened to TonyCorvette, but the working theory is that he and JoeSax35 were both disappeared in the middle of the night because they were getting too close to the truth. Black bags over their heads, flex-cuffs, the whole nine.

Some think it was the fda, but my sources are telling me it was Gilead Goons to blame. Also known as Gilead's Biktarmy, they handle the black ops side of their pharma business. From Albanian gangsters to crooked immunologists to supposed lawyers working out of their mom's basements. They're everywhere, and their sole purpose is to suppress Leronlimab at any cost.

Think about it.

When was the last time you held a saxophone in your hands? Like, really held it. Checked the keys and performed cunnilingus on the reed to make sure it was properly lubed up and ready to go? It's been ages, hasn't it? I mean, not long ago saxophones were everywhere. We all owned at least ten. You couldn't take two steps without someone trying to hand you their spare sax and convince you to play a Yakety Sax duet. That’s why therapists have been saying for over two years now that the number one nightmare reported by their patients is no longer about spiders or forgetting to put the $10 sell order in you’d planned to, but about Benny Hill, Baker Street, and the intro to Careless Whisper.

It’s pretty bad.

So it should be no big surprise to any of us that the Biktarmy has infiltrated our board. From JLang to TSOV to Lionel Hutz, it’s been a steady stream of people looking to disrupt Leronlimab’s ascension. And both Tony and Joe were on the frontlines, making sure we were ready. Or that just in case we missed something they could remind us. It was an invaluable service, and Gilead knew it. So they sent the Biktarmy after them. And if they aren’t dead they’re certainly being held against their will, otherwise they’d be here for every press release and absolutely nothing else. The TonyCorvette and JoeSax35 promise.

Oh, and I still write nonsense on occasion. Here’s a repost of the most recent hard-hitting science piece I wrote about pre-revenue biotech companies and their press releases:

Respert24’s Guide To Remaining Hopeful For Press Releases

This comprehensive guide gives readers effective tools for remaining hopeful in the face of company silence. If used correctly, studies have shown that readers maintain higher levels of endorphins (p-value < 0.0001), experience a two-fold increase in their ROI* (Renewed Optimism Index; p-value < 0.005), and for unknown reasons at this point of development, a 500% spike in Riboflavin (p-value < 0.000000002).

*For more information on ROI, please visit your local Respert24 headquarters which is temporarily located in the old Pizza Hut or House of Pancakes that shut down years ago.

Monday

When 8:30 on a Monday morning passes by with no press release email, fear not. For Monday is but the beginning of a long week where, quite literally, anything can happen. In fact, one could argue that putting out a press release on a Monday is a bad idea. They don’t call them “a case of the Mondays” because everyone is at their best. No, people are, rightfully, pissed off they have to go back to work where Linda continues to put out shit work that you again have to fix, and Ted’s bad breath is intensifying in a way that makes you wonder if there might actually be a dead raccoon in there somewhere. Logically it can’t be, as a mouth is only so big and raccoons are traditionally much larger than a human mouthal cavity (science term). But there’s just no other reason that comes to mind.

Yep, Monday morning is a bad time to kick off the week with a PR. Nobody is truly ready for it.

Which is why we hold out hope that after the bell we might get an announcement of news or a conference call where we anticipate big things being announced. See? We’ve already gotten over our disappointment for the morning. Buuuuuut, if we don’t get anything in the afternoon we’re right back in it. How could they? Who the hell is running this ship?

Monday Afternoon

Big Money, No Whammies!

Dammit. Nothing.

Which is when you tell yourself that afternoon is not the best time for big news. They’ll want to announce this in the morning to grab the market by the balls. Yep, it’s a good thing we didn’t get anything now when everyone has a whole night to lose the eye of the tiger, or worse yet forget completely as some new shiny ball bounces in from your periphery. That brings us to Tuesday.

Tuesday

Ahh, yes. Tuesday. The best possible day to have a morning PR in my humble opinion. We have a lot of week left ahead of us for the market to absorb the news and shorts to have to cover at higher levels. Surely we’ll get some news. Hell, we’re as overdue as a pay-by-mail toll.

But then 8:30 passes.

Shit. Or is it shit?

Didn’t we get our 8:30 email around 8:37 that one time? I think we did. Could be my email is slow, or could be that the company’s server just didn’t kick it out as quickly as it should. That’s probably it. We should wait another few minutes just to be safe. Don’t get all riled up for nothing, I always say.

But then 8:40 passes.

Double turds!

But hey, this is actually not so bad. In reality, a PR could come at any time, not just at 8:30. Because if we’re dropping a big partnership or licensing PR it’ll need to be coordinated with our partner. Presumably this partner is bigger than we are so we’ll probably drop the news at the preferred time of our suitor. So we wait. Maybe it’ll happen at 9am? That would be a great time to drop the news so there isn’t much time for the market makers to let their short or hedge fund buddies off the hook easily.

But then 9am passes and, you know what? That’s too close to the bell. We need 8:30 or earlier now that I think about it. So good, I’m glad it didn’t hit now. Perhaps after the market closes. Yep, that’s the move if I were Cytodyn.

Tuesday After The Bell

(Refer to Monday afternoon expectations and results)

Wednesday

Good ol’ Hump Day. What a glorious day for news. Still a good amount of week left, and surely the reason we didn’t get anything on Monday or Tuesday was that they were finalizing details. Not everyone works over the weekend. They probably sat down Monday and started working, with things bleeding into Tuesday. Give them time to let the lawyers do their thing and that brings us to 8:30am sharp, baby.

F*CK!

What the hell happened to our cadence and our accelerated timeline? It’s a Wednesday in early March for chrissakes!

*deep breath*

Ok, you know what? These things take time and thoughtful unveiling. They probably didn’t want to rush anything just to get it in the morning after the meetings adjourned. They have a few days to release news like this, so they’re going to do it right. Triple check everything. I like it. Strategery at its finest. Good on ‘em. You see, that’s why we got the new team in place. They’re killing it, as I've repeatedly said.

I bet we get something this afternoon. That gives them a full 24 hours to shape the PR for maximum efficacy and total destruction of the shorts.

Wednesday After The Bell

(Refer to Monday and Tuesday afternoon expectations and results)

Thursday

C’mon, baby! Thursday is the last reasonable day of the week to drop a PR as Friday’s are traditionally for bad news and there also isn’t much week to work with and we want this puppy to run.

8:30 passes with no news.

SONUFAMONKEY!

Am I crazy? How was there not a PR this morning? All signs were pointing to it. So what’s the deal?

Oh, I know. And this is pretty smart, actually. We’re probably going to get an announcement after the bell that we’re having a conference call next week. That’s when they drop our version of Fat Man on the world. It’ll be amazing. And we didn’t find out anything yet because there are a LOT of moving parts. I’m confident we’ll get all the t’s dotted and I’s crossed. Wait. Reverse that.

Afternoon passes with no news.

The only explanation is that we’ve had another big pharma enter the chat. Yep, right now they’re in the middle of a bidding war. That has to be it, otherwise we’d have had news this week for sure. I can see it now. Carl Gilead is panicking, chunking his bids up by $5-$10 billion every time he hears that Jeffrey Merck countered. Glaxo, Smith, and Kline are all left in the dust as they hit their ceiling tens of billions of dollars ago. It’s a war we know we’ll win, and win soon. Someone will run out of money. Surely we’ll know in the morning. Friday’s aren’t ideal, but this deal is erupting at the seams and a hungry market has their belt off ready to eat.

Friday

8:30 passes, 9:00 passes.

I’ve always said nobody in their right mind would drop news on a Friday when they can wait until Monday when the whole week is ahead of you. Smart move. Three dimensional chess, if I’m being honest. Kudos to management.

Friday Afternoon

NO WHAMMIES! NO WHAMMIES!

Whew! We’re clear. On to Monday, baby! It’s a new week and the absolute BEST week for dropping a frigging monster of a press release. It’s going to happen. Monday morning at 8:30am for sure. It's the best day, I've always known that and stated that publicly. Strap in. Get your affairs in order. Line up some of those other kinds of affairs. Eat filet. Crack the good bottle. Get that extra side of fries. We’ve earned it, everybody.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ROBOTWORLD 2026: AI Reshapes Industrial Horizons

Updated Category News Views 20

A Grand Gathering of Robotics Minds Walking into KINTEX, Seoul's suburban behemoth of an exhibition center, you'll find a buzz that rivals the excitement of a stock floor on earnings day. It's ROBOTWORLD 2026, a stage set for tech titans and ambitious startups alike, all throwing in their chips on AI and robotics. From November 4th to 7th, 402 companies hailing from 17...

Continue Reading
Synova Global Taps Eventus for Top Trade Surveillance

Updated Category News Views 163

Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...

Continue Reading
Are Insider Deals Jipping OPCH, PTC, RXO Shareholders?

Updated Category News Views 40

Let's Scrutinize These Big Transactions Alright, let's cut to the chase. We're seeing some big moves from Option Care Health, PTC Inc., and RXO Inc. that have us wondering if the shareholders are getting the short end of the stick. That's what Halper Sadeh LLC seems to think. They're rolling up their sleeves, investigating whether these companies have tossed aside their...

Continue Reading
Hemp Gift Guide Showcases Calm and Rest with CBD

Updated Category News Views 108

Digging Into Holiday Wellness Gifts In this age where peace can feel as elusive as a pot of gold, gifting something that whispers serenity and comfort has its charm. Enter Rare Cannabinoid Company, a Hawaii-based brand, weaving from their cannabinoid blend a holiday gift guide designed to infuse calm into the season's chaos. Now, that's something. A Unique Take on Holiday...

Continue Reading
Alfa Laval's Market Outlook: Strategic Plans Ahead

Updated Category News Views 32

Alfa Laval's Vision for the Future Alfa Laval is gearing up for a dynamic Capital Markets Day on November 18, 2026. The Swedish engineering giant, renowned for heat transfer, separation, and fluid handling solutions, is setting the stage to outline bold strategies and ambitious targets. Investors should pay attention, as the company's roadmap charts a course towards a SEK...

Continue Reading
PG&E, Edison Push Liability Cap Amid Firestorm

Updated Category News Views 93

The Thanksgiving Playbook Nobody Wanted Sacramento's corridors are buzzing with electric tension. And why? It's not some trivial turkey drama but a simmering scandal over two utility giants trying to sneak a liability cap into law faster than you can ask for a second slice of pumpkin pie. PG&E and Edison have a little secret—a covert strategy to limit shareholder...

Continue Reading
Pyramid Pharma Takes On 13th Blood Cancer Therapy Product

Updated Category News Views 78

Pyramid Pharma: Breaking New Ground in Blood Cancer Treatments There's a new player making waves in the battle against rare blood cancers: Pyramid Pharma Services. This U.S.-based contract development and manufacturing organization is stepping up its game by finessing a cartridge-based product designed to treat those rare and tricky blood maladies. The canvas? A...

Continue Reading
Baidu Faces Fraud Allegations: What Investors Should Know

Updated Category News Views 34

Trouble on the Horizon for Baidu Shareholders If you've got a pulse in the world of stock trading, you've likely caught wind of the storm brewing over at Baidu, Inc. (NASDAQ: BIDU). We're talking some heavy-duty allegations of securities fraud, and a class action lawsuit that's got investors scrutinizing their portfolios like never before. The lawsuit's been filed in the...

Continue Reading
Svea Mining Taps DNB Carnegie to Boost Liquidity

Updated Category News Views 54

Mining Moves and Market Churn Dusted off my boots and took a gander at Svea Mining AB. They’re a Swedish outfit that's rustling up some gold, copper, and silver out in the wilds of Northern Sweden. Now, they've got DNB and Carnegie stepping in as liquidity providers. Let me chew on this for a minute—why does a miner need a liquidity provider, you ask? It’s all about...

Continue Reading
Instanodes Tackling Quantum Threats in Blockchain

Updated Category News Views 172

Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...

Continue Reading

Top 5 Most Recently Viewed Articles

China's Ambitious Strategies for Economic Growth and Opening Up

Updated Category News Views 305

China's Vision for Economic Growth and Openness In recent discussions, major economic strategies unveiled by China's leaders emphasize high-standard opening up as a core element to drive high-quality development. As the nation refines its approach towards modernization, this focus is paramount in shaping the future economic landscape. The Hainan Free Trade Port: A New Era...

Continue Reading
Callan's New Direction with Research Visionary Pete Keliuotis

Updated Category News Views 34

New Leadership Sparks a Strategic Shift at Callan Out of the blue, Callan's latest move caught my eye, like spotting a wild card in a game of poker. Appointing Pete Keliuotis to head their Public and Private Markets Research isn't just a reshuffle; it's a bet on a vision for the future of investment consulting. The announcement came on June 10, 2026, with the change set...

Continue Reading
AEWIN Unveils Innovative Edge Computing Server for AI Solutions

Updated Category News Views 171

AEWIN Introduces the BAS-6101A Edge Computing Server AEWIN is set to capture attention at the upcoming trade show with its state-of-the-art BAS-6101A, a high-density edge computing server. This server, driven by a single AMD Zen5/Zen4c/Zen4 EPYC processor, is specifically designed for real-time and compute-intensive edge applications. The BAS-6101A stands out by offering...

Continue Reading
Revolutionizing Energy: The Future of Hydration and Vitality

Updated Category News Views 270

Revolutionizing Energy with Liquid I.V.® Energy drinks have long been dominated by products that often leave users feeling jittery, leading to sugar crashes that leave them drained. However, Liquid I.V.® is breaking the mold with its latest innovation: the Energy Multiplier® Sugar-Free. This new product is designed with a unique hydration-first approach, blending...

Continue Reading
Weyerhaeuser Company Announces New Quarterly Dividend Plans

Updated Category News Views 159

Weyerhaeuser Company Declares New Dividend on Common Shares Weyerhaeuser Company (NYSE: WY) has recently announced its decision regarding the upcoming quarterly dividend for its common stock. The board of directors has declared a base cash dividend of $0.21 per share. This dividend is a part of the company's ongoing efforts to return value to its shareholders and is...

Continue Reading